Global Treatment Access: Call for 95% Price Reduction; New GTAC Organization, Web Site

Global Treatment Access: Call for 95% Price Reduction; New GTAC Organization, Web Site

AIDS TREATMENT NEWS Issue #356, December 1, 2000
John S. James

Shortly before World AIDS Day (December 1), a coalition of AIDS and health groups including MSF (M decins Sans Fronti rs, or Doctors Without Borders) called on pharmaceutical companies to reduce prices of AIDS drugs 95% in poor countries--reductions comparable to those already in use for vaccines and contraceptives. MSF has carefully compiled information from generic drug manufacturers and other sources which indicates that the drugs could be sold profitably at that price. Price reductions up to 85% have already been offered by some companies, but even then drug costs approach $1,000 to treat each patient for one year-- much too expensive for most individuals and governments in poor countries.

The changing standard of care in rich countries (with doctors now waiting longer to begin antiretroviral treatment, reducing the number of patients who need to be treated), and possibly structured treatment interruption (see "Structured Treatment Interruption: Important Controlled Trial in Monkeys" in this issue) may also help to reduce costs, making top-quality treatment available for many patients who would otherwise have none. (These factors may not have been taken into account in the UNAIDS estimate of several billion dollars annually for "making a start" on antiretroviral therapy for sub-Saharan Africa.)

For recent information on international treatment-access activism, see the new Web site of the Global Treatment Access Campaign (GTAC), http://www.globaltreatmentaccess.org

Note: While this issue is dated December 1, it went to press too early to include announcements and other news released on that day.
001201
ATN35604

Copyright © 2000 - AIDS Treatment News. Permission granted for noncommercial reproduction, provided that our address and phone number are included if more than short quotations are used. Subscription lists are kept confidential. AIDS Treatment News, Subscription and Editorial Office: 1233 Locust St., 5th floor Philadelphia, PA 19107 800/TREAT-1-2 toll-free email: aidsnews@critpath.org http://www.aidsnews.org

Subscription Information: Call 800/TREAT-1-2: Businesses, Institutions, Professionals: $270/year. Includes early delivery of an extra copy by email. Nonprofit organizations: $135/year. Includes early delivery of an extra copy by email. Individuals: $120/year, or $70 for six months. Special discount for persons with financial difficulties: $54/year, or $30 for six months. If you cannot afford a subscription, please write or call. Outside North, Central, or South America, add air mail postage: $20/year, $10 for six months. Back issues available. Fax subscriptions, bulk rates, and multiple subscriptions are available; contact our office for details. Please send U.S. funds: personal check or bank draft, international postal money order, or travelers checks. VISA, Mastercard, and purchase orders also accepted. ISSN # 1052-4207

AEGiS is made possible through unrestricted grants from Boehringer Ingelheim, the National Library of Medicine, and donations from users like you. Always watch for outdated information. This article first appeared in 2000. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 2000. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .